Hasegawa Y - Search Results

1

Drug-induced Pneumonitis Following the Administration of TAS-102.

Hasegawa Y, Ota T, Tsukuda H, Suzumura T, Fukuoka M. Hasegawa Y, et al. Intern Med. 2016;55(19):2855-2859. doi: 10.2169/internalmedicine.55.6629. Epub 2016 Oct 1. Intern Med. 2016. PMID: 27725548 Free PMC article.

2

Migratory bone lesions in lymphoma.

Tsukuda H, Tsuya A, Hasegawa Y, Ota T, Fukuoka M. Tsukuda H, et al. Among authors: hasegawa y. QJM. 2022 Mar 22;115(3):177-178. doi: 10.1093/qjmed/hcac031. QJM. 2022. PMID: 35094089 No abstract available.

3

Erlotinib is a well-tolerated alternate treatment for non-small cell lung cancer in cases of gefitinib-induced hepatotoxicity.

Yonesaka K, Suzumura T, Tsukuda H, Hasegawa Y, Ozaki T, Sugiura T, Fukuoka M. Yonesaka K, et al. Among authors: hasegawa y. Anticancer Res. 2014 Sep;34(9):5211-5. Anticancer Res. 2014. PMID: 25202117

4

Catheter detachment.

Ota T, Tsukuda H, Tokunaga M, Nishida N, Hasegawa Y, Suzumura T, Fukuoka M. Ota T, et al. Among authors: hasegawa y. Oxf Med Case Reports. 2015 May 19;2015(5):292-3. doi: 10.1093/omcr/omv038. eCollection 2015 May. Oxf Med Case Reports. 2015. PMID: 26504585 Free PMC article. No abstract available.

5

Spontaneous pneumothorax due to bronchopleural fistula following reirradiation for locoregionally recurrent squamous cell lung cancer.

Ota T, Suzumura T, Sugiura T, Hasegawa Y, Yonesaka K, Makihara M, Tsukuda H, Tada T, Fukuoka M. Ota T, et al. Among authors: hasegawa y. Clin Case Rep. 2016 Apr 1;4(5):481-5. doi: 10.1002/ccr3.547. eCollection 2016 May. Clin Case Rep. 2016. PMID: 27190612 Free PMC article.

6

Abdominal pain under immunosuppressive conditions.

Ota T, Nakano M, Tanaka N, Suzumura T, Miyatake N, Hasegawa Y, Ozaki T, Tsukuda H, Fukuoka M. Ota T, et al. Among authors: hasegawa y. Cleve Clin J Med. 2016 Dec;83(12):874-875. doi: 10.3949/ccjm.83a.15143. Cleve Clin J Med. 2016. PMID: 27938521 Free article. No abstract available.

7

Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.

Hasegawa Y, Kawai S, Ota T, Tsukuda H, Fukuoka M. Hasegawa Y, et al. Immunotherapy. 2017 Aug;9(9):701-707. doi: 10.2217/imt-2017-0043. Epub 2017 Jun 26. Immunotherapy. 2017. PMID: 28649876

8

Use of hormone therapies in disseminated carcinomatosis of the bone marrow associated with hormone receptor-positive breast cancer.

Ota T, Miyatake N, Tanaka N, Hasegawa Y, Tokunaga M, Tsukuda H, Fukuoka M. Ota T, et al. Among authors: hasegawa y. Gynecol Endocrinol. 2018 Apr;34(4):286-289. doi: 10.1080/09513590.2017.1393063. Epub 2017 Oct 26. Gynecol Endocrinol. 2018. PMID: 29069999

9

False-Positive Elevation of CK-MB Levels with Chest Pain in Lung Adenocarcinoma.

Ota T, Hasegawa Y, Murata E, Tanaka N, Fukuoka M. Ota T, et al. Among authors: hasegawa y. Case Rep Oncol. 2020 Feb 11;13(1):100-104. doi: 10.1159/000505724. eCollection 2020 Jan-Apr. Case Rep Oncol. 2020. PMID: 32231530 Free PMC article.

10

Breast metastasis from EGFR-mutated lung adenocarcinoma: A case report and review of the literature.

Ota T, Hasegawa Y, Okimura A, Sakashita K, Sunami T, Yukimoto K, Sawada R, Sakamoto K, Fukuoka M. Ota T, et al. Among authors: hasegawa y. Clin Case Rep. 2018 Jun 19;6(8):1510-1516. doi: 10.1002/ccr3.1636. eCollection 2018 Aug. Clin Case Rep. 2018. PMID: 30147894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,672 results

Search Page